SCHEMBL3855280

SCHEMBL3855280

COc1ccc(C(=O)N2c3cc(F)ccc3-c3ccc(F)cc3C2C)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
HSD11B1 P28845 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.41
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
CRHBP P24387 1/20 0.39
KMT2A Q03164 1/20 0.39
CRHR2 Q13324 1/20 0.39
GPR35 Q9HC97 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3855301 0.92 GAA (0.44) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL3854734 0.92 ALDH1A1 (0.46) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL3856014 0.86 KMT2A (0.43) ALDH1A1LMNATSHRHTTMEN1
SCHEMBL3858289 0.86 KMT2A (0.43) ALDH1A1LMNATSHRHTTMEN1
SCHEMBL3858498 0.86 KMT2A (0.43) ALDH1A1LMNATSHRHTTMEN1
SCHEMBL3860967 0.81 ALDH1A1 (0.49) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL3860835 0.81 KMT2A (0.49) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL3856290 0.81 ESR1 (0.39) TSHRHSD11B1MEN1KMT2A
SCHEMBL3861316 0.79 KMT2A (0.49) TSHRMEN1CRHBPKMT2ACRHR2
SCHEMBL3855998 0.79 KMT2A (0.46) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585871-B2 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression WYETH (US) 2009-09-08 US disclosed
EP-1784391-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE EXPRESSION MODULATORS Wyeth (US) 2007-05-16 EP disclosed
US-20060058337-A1 Phenanthridine carbonyl phenols WYETH (US) 2006-03-16 US disclosed
WO-2006028875-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE MODULATORS WYETH (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058337-A1 Phenanthridine carbonyl phenols MT-CO2, PAH, CBR3 ALDH1A1 985/4885LMNA 1313/4885TSHR 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.